MedPath

Therapeutic Intervention in participants having deep carious lesion by Indirect Pulp Capping Treatment with three different biomaterials and evaluate the clinical and radiographic outcomes.

Phase 2
Conditions
Health Condition 1: K025- Dental caries on pit and fissure surface
Registration Number
CTRI/2024/05/067644
Lead Sponsor
arsinhbhai Patel Dental College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Tooth should be mature permanaent tooth showing closed apex in peroapical radiograph

2)Permanent posterior teeth with deep dentinal caries

3)Class I caries

4)teeth diagnosed with reversible pulpitis

5)Radiographically depth of caries should be more than 70 percentage or more than two thirds of dentin thickness

Exclusion Criteria

1)Deciduous teeth

2)Allergy to egg protein

3)No pulpal exposure post completion of caries removal

4)Teeth showing signs if irreversible pulpitis

5)Extensive pulpal carious lesion

6)Acute pulpal inflammation

7)Pulp Necrosis

8)Pathological Mobility

9)Tooth showing internal external resorption

10)Periapical Abscess

11)Fistula

12)Patient on antibiotic or analgesic course within a week prior to the start of treatment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determine which pulp capping agent has higher efficacy in pulp capping treatmentTimepoint: 1, 3,6 and 9 months
Secondary Outcome Measures
NameTimeMethod
To compare and evaluate efficacy of EggShell derived Hydroxyapatite, Biodentine and Theracal LC as IPC agent clinically by <br/ ><br>checking postoperative pain, tenderness, neural sensibility, and radiographically by <br/ ><br>checking PDL space widening, presence of calcific barrier and periapical <br/ ><br>radiolucencyTimepoint: 1, 3,6 and 9 months
© Copyright 2025. All Rights Reserved by MedPath